GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chia Tai Enterprises International Ltd (HKSE:03839) » Definitions » Other Net Income (Loss)

Chia Tai Enterprises International (HKSE:03839) Other Net Income (Loss) : HK$-0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Chia Tai Enterprises International Other Net Income (Loss)?

Chia Tai Enterprises International's Other Net Income (Loss) for the three months ended in Dec. 2024 was HK$0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-0 Mil.

Chia Tai Enterprises International's quarterly Other Net Income (Loss) increased from Jun. 2024 (HK$-0 Mil) to Sep. 2024 (HK$0 Mil) but then stayed the same from Sep. 2024 (HK$0 Mil) to Dec. 2024 (HK$0 Mil).

Chia Tai Enterprises International's annual Other Net Income (Loss) declined from Dec. 2022 (HK$0 Mil) to Dec. 2023 (HK$-0 Mil) and declined from Dec. 2023 (HK$-0 Mil) to Dec. 2024 (HK$-0 Mil).


Chia Tai Enterprises International Other Net Income (Loss) Historical Data

The historical data trend for Chia Tai Enterprises International's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chia Tai Enterprises International Other Net Income (Loss) Chart

Chia Tai Enterprises International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Chia Tai Enterprises International Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Chia Tai Enterprises International Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chia Tai Enterprises International Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Chia Tai Enterprises International's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Chia Tai Enterprises International Business Description

Traded in Other Exchanges
N/A
Address
16 Harcourt Road, 21st Floor, Far East Finance Centre, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China which generates key revenue, Asia Pacific (excluding mainland China), Americas, Europe, and Others.

Chia Tai Enterprises International Headlines

No Headlines